Francisco
Marin Ortuño
Profesores Titulares de Universidad Vinculados H.V.Arrixaca
Hospital Universitario La Fe
Valencia, EspañaPublications in collaboration with researchers from Hospital Universitario La Fe (21)
2024
-
Incidence and clinical impact of inappropriate periprocedural and perioperative management of antiplatelet therapy
Medicina Clinica, Vol. 163, Núm. 7, pp. 336-343
-
Periprocedural use of antithrombotic therapy in interventional cardiology in Spain: are we doing better than other specialties?
Revista Espanola de Cardiologia, Vol. 77, Núm. 8, pp. 701-703
2023
-
Changes in echocardiographic parameters over time in paradoxical low-flow low-gradient aortic stenosis
European heart journal. Cardiovascular Imaging, Vol. 24, Núm. 8, pp. 1120-1128
-
Prospective observational registry of perioperative and periprocedural management of antithrombotic therapy in “real world”: the REQXAA study
Revista Espanola de Cardiologia, Vol. 76, Núm. 9, pp. 729-738
2021
-
Clinical Risk Prediction in Patients With Left Ventricular Myocardial Noncompaction
Journal of the American College of Cardiology, Vol. 78, Núm. 7, pp. 643-662
2018
-
Perioperative and Periprocedural Management of Antithrombotic Therapy: Consensus Document of SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT and AEU
Revista Espanola de Cardiologia, Vol. 71, Núm. 7, pp. 553-564
2016
-
Interhospital Variability in Drug Prescription after Acute Coronary Syndrome: Insights from the ACDC Study
Revista Espanola de Cardiologia, Vol. 69, Núm. 2, pp. 117-124
2015
-
Involvement of the -420C>G RETN polymorphism in myocardial fibrosis in patients with hypertrophic cardiomyopathy
Journal of Internal Medicine, Vol. 278, Núm. 1, pp. 50-58
-
TWEAK and NT-proBNP levels predict exercise capacity in hypertrophic cardiomyopathy
European Journal of Clinical Investigation, Vol. 45, Núm. 2, pp. 179-186
2013
-
Drug-eluting stents for off-label indications in real clinical world: Evidence based or 'intuition' based clinical practice?
International Journal of Cardiology, Vol. 164, Núm. 1, pp. 116-122
2011
-
Reducción de la mortalidad precoz y a 6 meses en pacientes con IAM en el periodo 1995-2005. Datos de los registros PRIAMHO I, II y MASCARA
Revista Espanola de Cardiologia, Vol. 64, Núm. 11, pp. 972-980
2009
-
Antithrombin Cambridge ll (A384S) supports a role for antithrombin deficiency in arterial thrombosis
Thrombosis and Haemostasis, Vol. 101, Núm. 3, pp. 483-486
-
Insights into the role of microRNAs in cardiac diseases: From biological signalling to therapeutic targets
Cardiovascular and Hematological Agents in Medicinal Chemistry, Vol. 7, Núm. 1, pp. 82-90
-
Patient registries of acute coronary syndrome assessing or biasing the clinical real world data?
Circulation: Cardiovascular Quality and Outcomes, Vol. 2, Núm. 6, pp. 540-547
2008
-
AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms
Haematologica, Vol. 93, Núm. 5, pp. 729-734
-
Endothelial protein C receptor polymorphisms and risk of myocardial infarction
Haematologica, Vol. 93, Núm. 9, pp. 1358-1363
2006
-
Maximum longitudinal relaxation velocity of the left ventricle: Its clinical value and relationship with NT-proBNP plasma levels in heart failure
Echocardiography, Vol. 23, Núm. 4, pp. 295-302
-
Valores de 8-hidroxi-2'-desoxiguanosina y de peroxidación lipídica en pacientes con insuficiencia cardiaca
Revista Espanola de Cardiologia, Vol. 59, Núm. 11, pp. 1140-1145
2005
-
Relación de los valores plasmáticos de big endotelina-1 con Nt-proBNP y la función ventricular de pacientes con insuficiencia cardíaca
Revista Espanola de Cardiologia, Vol. 58, Núm. 3, pp. 278-284
2004
-
Hipertensión y valores de NT-proBNP. Su importacia en el diagnóstico de insuficiencia cardíaca
Revista Espanola de Cardiologia, Vol. 57, Núm. 5, pp. 396-402